RPS9 and non-small cell lung carcinoma: They showed that BRCAT54 was downregulated in both NSCLC tumors and cells, and BRCAT54 could positively regulate the growth of NSCLC tumors by directly binding to RPS9, thereby by regulating the JAK-STAT pathway [17].